Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Chemo-Refractory or Previously Untreated Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Treosulfan (Primary) ; Fludarabine
- Indications Acute myeloid leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
- Focus Therapeutic Use
- 02 Dec 2015 Biomarkers information updated
- 03 Dec 2012 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 24 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.